Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:HYPR NASDAQ:INGN NASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$4.47+4.2%$3.84$1.55▼$4.69$179.64M1.39171,528 shs318,974 shsHYPRHyperfine$1.38-8.0%$1.39$0.66▼$2.22$148.91M1.38556,481 shs424,075 shsINGNInogen$6.41+1.6%$6.59$5.34▼$9.13$170.84M1.6404,116 shs466,983 shsSTRRStar Equity$11.30-3.0%$10.15$8.26▼$11.99$43.06M0.497,326 shs12,595 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+13.19%+3.37%+53.76%+37.50%+158.43%HYPRHyperfine+0.67%-6.25%-12.28%+40.19%+111.51%INGNInogen+5.52%-3.52%-10.50%-2.47%-1.71%STRRStar Equity-0.65%-1.67%+19.34%+13.95%+401.09%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$4.47+4.2%$3.84$1.55▼$4.69$179.64M1.39171,528 shs318,974 shsHYPRHyperfine$1.38-8.0%$1.39$0.66▼$2.22$148.91M1.38556,481 shs424,075 shsINGNInogen$6.41+1.6%$6.59$5.34▼$9.13$170.84M1.6404,116 shs466,983 shsSTRRStar Equity$11.30-3.0%$10.15$8.26▼$11.99$43.06M0.497,326 shs12,595 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+13.19%+3.37%+53.76%+37.50%+158.43%HYPRHyperfine+0.67%-6.25%-12.28%+40.19%+111.51%INGNInogen+5.52%-3.52%-10.50%-2.47%-1.71%STRRStar Equity-0.65%-1.67%+19.34%+13.95%+401.09%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate Buy$6.5045.41% UpsideHYPRHyperfine 2.33Hold$1.7829.23% UpsideINGNInogen 2.67Moderate Buy$14.00118.41% UpsideSTRRStar Equity 2.20Hold$28.00147.79% UpsideCurrent Analyst Ratings BreakdownLatest STRR, INGN, APYX, and HYPR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/20/2026STRRStar Equity Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/13/2026HYPRHyperfine B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/8/2026INGNInogen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/6/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/29/2026HYPRHyperfine BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$2.004/21/2026HYPRHyperfine Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/7/2026INGNInogen Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy3/27/2026APYXApyx Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/23/2026STRRStar Equity Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$21.00 ➝ $28.003/19/2026HYPRHyperfine Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$52.84M3.54N/AN/A$0.39 per share11.46HYPRHyperfine$11.40M12.02N/AN/A$0.42 per share3.29INGNInogen$348.67M0.50N/AN/A$7.08 per share0.91STRRStar Equity$172.16M0.24$0.61 per share18.39$19.12 per share0.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$11.21M-$0.22N/AN/AN/A-16.40%-88.47%-14.94%8/6/2026 (Estimated)HYPRHyperfine-$35.57M-$0.41N/AN/AN/A-226.88%-98.83%-67.09%8/12/2026 (Estimated)INGNInogen-$22.75M-$0.91N/AN/AN/A-7.08%-12.90%-8.27%8/6/2026 (Estimated)STRRStar Equity-$5.92M-$2.63N/A10.87N/A-4.18%-4.04%-2.40%8/6/2026 (Estimated)Latest STRR, INGN, APYX, and HYPR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026HYPRHyperfine-$0.09-$0.09N/A-$0.09$3.54 million$3.90 million5/11/2026Q1 2026STRRStar Equity$0.05-$0.99-$1.04-$1.17$52.57 million$50.06 million5/7/2026Q1 2026APYXApyx Medical-$0.11-$0.05+$0.06-$0.05$10.53 million$12.49 million5/7/2026Q1 2026INGNInogen-$0.24-$0.30-$0.06-$0.30$82.35 million$85.11 million3/18/2026Q4 2025HYPRHyperfine-$0.08-$0.06+$0.02-$0.06$5.30 million$5.29 million3/17/2026Q4 2025STRRStar Equity$0.13-$0.10-$0.23-$0.67$59.08 million$56.79 million3/10/2026Q4 2025APYXApyx Medical-$0.06-$0.03+$0.03-$0.03$19.12 million$19.16 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AHYPRHyperfineN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical2.685.804.79HYPRHyperfine0.385.524.90INGNInogenN/A3.102.70STRRStar Equity0.092.091.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%HYPRHyperfine15.03%INGNInogen89.94%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%HYPRHyperfine26.33%INGNInogen2.50%STRRStar Equity33.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27041.87 million35.51 millionOptionableHYPRHyperfine19099.27 million73.13 millionOptionableINGNInogen1,03027.08 million26.40 millionOptionableSTRRStar Equity1,2003.70 million2.46 millionNot OptionableSTRR, INGN, APYX, and HYPR HeadlinesRecent News About These CompaniesJeffrey Eberwein Purchases 1,430 Shares of Star Equity (NASDAQ:STRR) StockJune 5 at 8:54 AM | insidertrades.comContrasting Paranovus Entertainment Technology (NASDAQ:PAVS) & Star Equity (NASDAQ:STRR)June 5 at 4:13 AM | americanbankingnews.comStar Equity (NASDAQ:STRR) Director Acquires $11,600.00 in StockJune 3 at 6:44 AM | insidertrades.comStar Equity (NASDAQ:STRR) CEO Acquires $17,176.38 in StockJune 2 at 5:34 AM | insidertrades.comStar Equity Holdings, Inc. to Present at Noble Capital Markets Emerging Growth Virtual Conference on June 3-4, 2026June 1, 2026 | quiverquant.comQStar Equity Holdings to Present at the Noble Capital Markets Emerging Growth Virtual Conference on June 3-4June 1, 2026 | globenewswire.comStar Equity (NASDAQ:STRR) CEO Buys $26,906.88 in StockMay 28, 2026 | insidertrades.comContrasting Sumitomo (OTCMKTS:SSUMY) and Star Equity (NASDAQ:STRR)May 27, 2026 | americanbankingnews.comInsider Stock Buying Reaches US$4.21m On Star Equity HoldingsMay 22, 2026 | finance.yahoo.comInsider Buying: Star Equity (NASDAQ:STRR) CEO Buys 4,198 Shares of StockMay 22, 2026 | insidertrades.comStar Equity Launches ATM Preferred Stock Offering ProgramMay 18, 2026 | tipranks.comStar Equity Declares Cash Dividend on Preferred StockMay 15, 2026 | tipranks.comStar Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred StockMay 15, 2026 | globenewswire.comStar Equity Holdings: Q1 Earnings SnapshotMay 11, 2026 | khou.comKStar Equity Holdings (STRR) Reports Q1 Loss, Misses Revenue EstimatesMay 11, 2026 | zacks.comStar Equity Holdings Reports Strong Q1 Revenue Growth and Achieves $2.6 Million in Merger SynergiesMay 11, 2026 | quiverquant.comQStar Equity Holdings Reports 2026 First Quarter ResultsMay 11, 2026 | globenewswire.comStar Equity Holdings to Release First Quarter 2026 Financial Results on May 11May 6, 2026 | globenewswire.comStar Equity Holdings Announces Proposal to Acquire GEE Group for $0.30 per ShareMay 6, 2026 | globenewswire.comStar Equity Fund Calls on GEE Group to Change Egregious Executive Employment AgreementsApril 29, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSTRR, INGN, APYX, and HYPR Company DescriptionsApyx Medical NASDAQ:APYX$4.47 +0.18 (+4.20%) Closing price 04:00 PM EasternExtended Trading$4.49 +0.02 (+0.40%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Hyperfine NASDAQ:HYPR$1.38 -0.12 (-8.00%) Closing price 04:00 PM EasternExtended Trading$1.45 +0.07 (+5.07%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Inogen NASDAQ:INGN$6.41 +0.10 (+1.58%) Closing price 04:00 PM EasternExtended Trading$6.40 0.00 (-0.08%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Star Equity NASDAQ:STRR$11.30 -0.35 (-3.00%) Closing price 03:55 PM EasternExtended Trading$11.16 -0.14 (-1.24%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
